Biomarkers for Babesia
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying babesia status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with babesia or not infected with babesia. The biomarkers can be detected by SELDI mass spectrometry.
19 Citations
103 Claims
-
1-88. -88. (canceled)
-
89. A method for qualifying babesia status in a subject comprising:
-
measuring at least one biomarker in a biological sample from the subject, wherein the at least one biomarker is selected from the group consisting of the biomarkers of Table 1, Table 2, and Table 3; and correlating the measurement -with babesia status. - View Dependent Claims (95, 96, 97)
-
-
90. A method for determining the course of babesia comprising:
-
measuring, at a first time, at least one biomarker in a biological sample from the subject, wherein the at least one biomarker is selected from the group consisting of the biomarkers of Table 1, Table 2, and Table 3; measuring, at a second time, the at least one biomarker in a biological sample from the subject; and comparing the first measurement and the second measurement;
wherein the comparative measurements determine the course of babesia.
-
-
91. A method comprising measuring at least one biomarker in a sample from a subject, wherein the at least one biomarker is selected from the group consisting of biomarkers of Table 1, Table 2, and Table 3.
-
92. A kit comprising:
a solid support comprising at least one capture reagent attached thereto, wherein the capture reagent binds at least one biomarker from a first group consisting of the biomarkers of Table 1, Table 2 and Table 3. - View Dependent Claims (93, 94)
-
98. A composition comprising a purified biomolecule selected from the group consisting of the biomarkers of Table 1, Table 2, and Table 3.
-
99. A composition comprising a biospecific capture reagent that specifically binds a biomolecule selected from group consisting of the biomarkers of Table 1, Table 2, and Table 3.
-
100. A composition comprising a biospecific capture reagent bound to a biomarker of Table 1, Table 2, and Table 3.
-
101. A software product comprising:
- a) code that accesses data attributed to a sample, the data comprising measurement of at least one biomarker in the sample, the biomarker selected from the group consisting of the biomarkers of Table 1, Table 2, and Table 3; and
b) code that executes a classification algorithm that classifies the <
disease>
status of the sample as a function of the measurement.
- a) code that accesses data attributed to a sample, the data comprising measurement of at least one biomarker in the sample, the biomarker selected from the group consisting of the biomarkers of Table 1, Table 2, and Table 3; and
-
102. A method comprising detecting a biomarker of Table 1, Table 2, or Table 3 by mass spectrometry or immunoassay.
-
103. A method for identifying a compound that interacts with a biomarker of Table 1, Table 2 or Table 3 wherein said method comprises:
- a) contacting a biomarker of Table 1, Table 2, or Table 3 with a test compound; and
b) determining whether the test compound interacts with a biomarker of Table 1, Table 2, or Table 3.
- a) contacting a biomarker of Table 1, Table 2, or Table 3 with a test compound; and
Specification